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injections of LPS (and after the initial cytokine release) also prevented 
organ injury and death. In contrast, intervention with anti-TNF 
antibody did not provide significant protection. These results support 
the concept that blocking CDl4 in human septic shock may limit 
hypotension, disseminated intravascular coagulation and organ injury 
reculting from cuniulative exposures to LPS. 
Immune reconstitution in HIV disease 
ml Antiviral therapy of HIV infection 
I.V.D. Weller. Royal  Free and Uiiversiry College Medical Sihool, 
Lhitwsity Collqe Londow, London, UK 
In developed countries, potent combination therapy has led to 
important reductions in morbidity, mortality and hospitalization. 
However, at the same time, as always, we face new challenges. To 
what extent these effects will be sustained is not known. Resources 
and outpatient facilities are being ‘stretched. Poor compliance with 
complicated drug treatments requires a simplification of regimens. 
There is evidence of low-level replication continuing in the face of 
an apparent ‘suppression’ of replication, and together with sanctuary 
sites of virus division, the emergence of resistance in the longer term 
seems inevitable. Resistance may cross drug classes, reducing 
therapeutic options for change. Immune reconstitution is largely 
partial, heightening interest in supplementary immune-based thera- 
pies. Resistance testing is ‘leaking’ into clinical practice before we 
really know how urefuI it is, and when to  start therapy, when to 
change, what to use and how best to sequence drugs are vital 
questions that we need to address. 
wl Maintenance and prophylactic treatment of 
opportunistic infections during HAART 
M.A. Jacobson. Lhitwsi ty  .f Cnl$rnia, San Fraricisco, C4,  [ JSA4 
HAART has profoundly affected the incidence of common AIDS- 
related opportunistic infections (01s) in countries where this therapy 
is widely available. In the USA and western Europe, the incidence of 
C X  such as Pnruniocystis carinii pneumonia (PCP), disseminated 
Alyn)/iaiteriuw~ uvinm complex infection (MAC) and cytoniegalovirus 
end-organ disease (CMV) is now 20% of that in 1994. However, the 
incidence does not appear to have decreased further since 1997. 
There have been several recent reports of individual AIDS patients 
with MAC and CMV on  maintenance therapy for these 01s who, 
after their CD4 count rose to 100 cells/(L on HAART, have discon- 
tinued maintenance therapy without 01 relapse after up to 1 year of 
follow-up. There are also reports of small series of patients who were 
receiving PCP or MAC prophylaxis for CD4 counts <?OO or  50 and 
who, aher their CD4 count row to 200 or  lO(1 ceUs/(L on  HAART, 
have discontinued prophylaxis without developing these 0 1 s .  
However, it is not possible to accurately predict which patients with 
prior low CD4 counts who have responded to HAART can safely 
discontinue 01 maintenance or  prophylaxis treatment. Observational 
studies are in progress to better define markers of01 protection. These 
include pathogen-specific immune function and T-cell phenotype 
assays in addition to standard CD4 and I-UV R N A  measurements. 
Pending results of these trials, continued maintenance and pro- 
phylaxis should be based on nadir CD4 counts unless the risk of anti- 
0 1  drug adverse effects is substantial. 
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I S61 I Evolution of resistance mechanisms- 
intelligent bacterial solutions to combat 
antibiotic attack 
P. Heisig. Pilamiaceuticai AliiroDiolo~y, L’nirwsify cf Borm, Germany 
It is generally assumed that a pool of resittance genes evolved in 
antibiotic-producing microorganisms before antibiotics were u\ed fix 
treatment of infectious diseases. These genes code for antibiotic.- 
inactivating enzymes, like beta-lactamases, as well as target-modif+g 
enzymes like rRNA niethylases. Moreover, efflux pumps reducing 
the intracellular drug concentration have evolved with narrow o r  
broad substrate specificities. The  spread of the corresponding re\i\t- 
ance genes among different bacteria seems to have been primarily 
influenced by the local selective pressure within the natural environ- 
ment. However, during the last decade, conditions of selection have 
changed rapidly due to the intensive use of antibiotics and the 
development of new drugs. But within a short period of time, 
bacteria have developed effective defense mechanisms against every 
new drug introduced. Besides the transfer of preformed reristance 
determinants, point mutations have played a major role in this short- 
term resistance development. These point mutations have affected 
not only genes coding for already existing inactivating enzymes (a‘ i~4 ,  
tila) or regulatory elements controlling efflux pumps (nwz4, mcx), but 
also genes coding for targets of antibiotic action. These include genes 
like rpoB, coding for the target of rifampin, or  genes yyr’4 m d  ynrC,  
coding for the A subunits oftype I1 topoisomerases, DNA gyrase and 
topoisomerase IV, respectively These are the tax-gets inhibited by the 
synthetic quinolones. Due to the high antibacterial activity of new 
fluorinated quinolones against E.  coli, a combination of mutationr is 
required for clinically relevant levels of resirtance. Observations with 
laboratory strains suggest that the accumulation of rerittance muta- 
tions siinultaneously reduces the viability. Thus, additional mutations, 
not necessarily affecting resistance, are aqsumed to restore fitness, a5 
has been observed in fluoroquinolone-resistant clinical isolates. 
Quorum sensing: the language of 
Gram-negative bacteria 
G. Hartman, Greenwich Hcaltlicare Nh’S  Tkv,  Dcp. of Medical 
hlicrohiology, London, UK 
The  discovery of N-acyl-L-homoserine lactone molecules as the 
signaling mechanism in Pliofobmrriuni ( I  ‘ibuio) j s c h e r i  to \en\e m d  
respond to their own density in the light organr of certain fish in 
order to bring about the quorum rerponre of bioluminescence has 
led to the elucidation of similar mechanisms in an ever-increasing 
number of Gram-negative organisms-to the extent that quorum 
sensing appears to be a universal lanpage of Grani-negative bacteria. 
In at least one human pathogen, Psc~~domi~inas erqinosa, quorum 
sensing appears to control the expresion of numerous virulence 
factors such as elastase, exotoxin A, pyocyanin, alkaline proteate, 
cyanide and hemolytin. Interestingly, there even appears to be the 
capability of interspecies communication, with Burkholdcrio ctpacio 
being able to sense and respond to the density of Pseudomunus 
aerqinosa in the lungs of cystic fibrotic patients. Uvng a model bascd 
on the luminescence operon of Photobaiferinm js iheri ,  several poten- 
tial mechanisms to disrupt quorum sensing, and, hence. patho- 
genicity, may be possible. Currently, the most attractive of these i\  t o  
use compounds resembling the n’-acyl-L-honioseriiie lactone 
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molecules, which then act in competition for the activation sites of 
the operbns or regulons under quorum sensing control. Control of 
pathogenicity in this way may offer a unique form of antimicrobial 
therapy without the endotoxemia associated with Gram-negative cell 
lysis. 
FI A new approach for controlling bacterial popu- 
lations (sonic communication with bacterial 
M. Matsushashi, A.N. Pankrushina, K. Endoh, S. Endo, 
H. Ohshima, S. Takeuchi, A. Shindo, M. Tobi, H. Yamamura, 
T. Tomari, E. Masaka, S. Hiraoka, N. Hiraoka, S. Takayanagi, 
A. Fujino. Tokai University, Biological Science, Numazu, japan 
Introduction and  objectives: We previously reported that bacteria 
communicate with each other by using growth-regulating sonic/ 
ultrasonic signals (Matsuhashi et al, J Gen Appl Microbiol 1996; 42: 
315-323). Barillus subtilis cells emit sounds at frequencies ofabout 8.5 
kHz and its overtones, and the growth of B. carboniphilus cells is 
promoted by sounds/ultrasounds from a speaker at similar frequencies 
under non-permissive stress conditions (Matsuhashi et al, J Gen Appl 
Microbiol 1998; 44: 49-55). Graphite, charcoal and other materials 
convert external energy, such as pulses of infrared light, into sonic 
signals (Matsuhashi et al, J Gen Appl Microbiol 1997; 43: 225-230). 
The response of bacteria to sounds may be utilized in antibiotic 
therapy. 
Results: (1) Soft solid matter, such as solidified agar in growth 
media, can significantly promote or inhibit the growth of bacteria 
and yeast under stress conditions and the hatching of fish eggs. The 
effect is probably due to photo-acoustic emission resulting from the 
conversion of external electromagnetic energy and can be diminished 
by shielding the agar and organisms with aluminum foil. E. coli and 
yeasts also responded to signals from the agar. This mechanism 
probably explains why many bacteria and mycoplasmas grow well on 
soft solid surfaces such as animal tissue. (2) In contrast to B. 
carboniphilus, soft low-frequency sounds from a speaker, at frequencies 
between 10 and 800 Hz, markedly inhibit the growth of E. coli. This 
E. coli behavior, which may be common in related Gram-negative 
bacilli, suggests that low-frequency sounds may help to overcome 
infections by Gram-negative bacteria. 
w] Quorum sensing-a new target for antibiotic 
therapy 
P. Williams. University $ Nottingham, Pltarinacrutical Sciences/lnstitute 
o f  Infections G University Park, Nottingham, UK 
There are two broad strategies for controlling bacterial infection: 
either (1) kill the organism or (2) attenuate virulence such that the 
infecting oragnism fails to adapt to the host environment and can be 
cleared by the innate host defenses. The latter approach has, until 
recently, lacked specific targets for rational drug design. However, the 
discovery that bacterial cells communicate with each other using 
small diffusible signaling molecules to regulate virulence in concert 
with cell population density (termed quorum sensing) now offers 
such a novel target. 
Many Gram-negative bacteria employ N-acylhomoserine lactones 
(AHLs) as quorum sensing signaling molecules which not only 
control gene expression but also possess potent pharmacologic 
activities such that they may function as virulence determinants per 
se. Understanding the molecular mechanisms by which AHLs are 
produced (usually via a member of the Lux family of AHL synthases) 
and by which AHLs activate target gene expression (via members of 
thr LuxR family of transcriptional regulators) is central to the design 
of small-molecule antagonists (Quorum Sensing Blockers, QSBs) 
capable of attenuating virulence through the blockade of either signal 
generation or signal transduction. 
Toxicity of antimicrobial agents: relevance of 
preclinicai data for the clinician 
Is671 Immunologic reactions to antimicrobial agents 
A. Cerny. I t d p i r d  / Deparrmrnt of Innere Medizin, Berne, 
Switzerland 
This presentation reviews the incidence, clinical manifestations, 
differential diagnosis, risk factors and pathogenesis of allergic 
reactions of two important classes of antimicrobials; beta-lactams and 
sulfonamides. The diagnostic work-up of a patient with a history of 
an allergic reaction will be discussed, as well as the possibility of the 
safe administration of the drug in the face of an allergy using 
immunotherapy Emerging concepts of beta-lactam side-chain 
allergy, the role of cellular immune mechanisms and the clinical 
importance of cross-reactivity of allergic reactions to different classes 
of beta-lactams will be emphasized. 
Is681 Toxic effects of antimicrobial agents on the 
musculoskeletal system 
R. Stahlmann. Freie Universitiit Berlin, Institutfur Toxikologie, Berlin, 
Germany 
Several groups of antimicrobial agents have the potential to have 
adverse effects on the musculoskeletal system. At the beginning of 
the 1960s, the effects of tetracycline on the developing skeleton were 
investigated in premature infants by multiple X-ray examinations. 
Based on these results, tetracylines were considered to be contra- 
indicated in infants and children. Quinolones are another group of 
frequently used drugs that have toxic effects on connective tissue 
structures. Due to their cartilage toxicity-as shown in immature 
dogs and other animals-they are contraindicated in children and 
adolescents. Human experience with pefloxacin in children showed 
an unacceptably high incidence of joint toxicity (10%). However, 
with nalidixic acid, norfloxacin and ciprofloxacin, favorable clinical 
results in juvenile patients have been published. Also, quinolones have 
the potential to induce tendon disorders (tendinitis, Achilles tendon 
rupture) which have occurred mainly in elderly patients. Mechanistic 
studies from our group indicate that the magnesium-chelating 
properties of the quinolones might be responsible for these toxic 
effects. Less often used antimicrobial drugs which might affect the 
musculoskeletal system include, for example, pyrazinamide, rifabutin, 
and quinupristin-dalfopristin. 
Infectious disease problems in Central and 
Eastern Europe 
Typical problems of infectious diseases in 
Central Europe 
E. Ludwig. Petefy Eachiny Hospital, Budapest, Hungary 
Central and eastern European countries face the same types of 
